{"transactions":[{"id":4624226,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-18T22:03:05.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":4891,"price":199.3032,"value":974791.9512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 56,713 restricted stock units."}],"balance_after":149680,"source":{"system":"sec-edgar","filing":"0001294192-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000129419226000007/ownership.xml","form_type":"4"}},{"id":4624225,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-18T22:03:05.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":76,"price":195.0083,"value":14820.6308,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $195.00 to $195.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":154571,"source":{"system":"sec-edgar","filing":"0001294192-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000129419226000007/ownership.xml","form_type":"4"}},{"id":733838,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":25725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2023 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":114275,"derivative":{"exercise_price":26.5,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":25725},"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733837,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":3302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":71750,"derivative":{"exercise_price":29.8,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":3302},"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733836,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":75075,"derivative":{"exercise_price":40.74,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":573},"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733835,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":44854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":75052,"derivative":{"exercise_price":29.8,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":44854},"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733834,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":15546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":75648,"derivative":{"exercise_price":40.74,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":15546},"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733833,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":29600,"price":160.1243,"value":4739679.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades in prices ranging from $160.00 to $160.48, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 66,201 RSUs."}],"balance_after":154647,"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733832,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":25725,"price":26.5,"value":681712.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 66,201 RSUs."}],"balance_after":184247,"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733831,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":3302,"price":29.8,"value":98399.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 66,201 RSUs."}],"balance_after":158522,"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733830,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":573,"price":40.74,"value":23344.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 66,201 RSUs."}],"balance_after":155220,"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733829,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T23:51:47.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":3575,"price":156.1193,"value":558126.4975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of RSUs after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades in prices ranging from $156.1105 to $156.8250, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 66,201 RSUs."}],"balance_after":154647,"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733828,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":60400,"price":160.1706,"value":9674304.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $160.00 to $160.3550, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units (\"RSUs\")."}],"balance_after":158222,"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733827,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":44854,"price":29.8,"value":1336649.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units (\"RSUs\")."}],"balance_after":218622,"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":733826,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-17T23:51:47.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":15546,"price":40.74,"value":633344.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units (\"RSUs\")."}],"balance_after":173768,"source":{"system":"sec-edgar","filing":"0001610717-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000230/form4.xml","form_type":"4"}},{"id":737650,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"exercise","planned":true,"acquired":false,"shares":8906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":91194,"derivative":{"exercise_price":40.74,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":8906},"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737649,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"exercise","planned":true,"acquired":false,"shares":1094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."}],"balance_after":0,"derivative":{"exercise_price":42.45,"exercise_date":"2023-08-09","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":1094},"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737648,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":200,"price":150.17,"value":30034.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units."}],"balance_after":158222,"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737647,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":4600,"price":149.6429,"value":688357.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades in prices ranging from $149.17 to $150.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units."}],"balance_after":158422,"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737646,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":148.7231,"value":267701.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades in prices ranging from $148.14 to $149.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units."}],"balance_after":163022,"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737645,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":500,"price":147.272,"value":73636.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades in prices ranging from $147.06 to $147.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units."}],"balance_after":164822,"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737644,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":700,"price":146.0371,"value":102225.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades in prices ranging from $145.88 to $146.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units."}],"balance_after":165322,"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737643,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":885,"price":145.1495,"value":128457.3075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades in prices ranging from $144.79 to $145.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units."}],"balance_after":166022,"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737642,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":1315,"price":144.2793,"value":189727.2795,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $143.78 to $144.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units."}],"balance_after":166907,"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737641,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"exercise","planned":true,"acquired":true,"shares":8906,"price":40.74,"value":362830.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units."}],"balance_after":168222,"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":737640,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:05:58.000Z","date":"2026-06-11","kind":"exercise","planned":true,"acquired":true,"shares":1094,"price":42.45,"value":46440.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026."}],"balance_after":159316,"source":{"system":"sec-edgar","filing":"0001610717-26-000216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000216/form4.xml","form_type":"4"}},{"id":833318,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-19T22:56:03.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":4583,"price":99.4804,"value":455918.6732,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,050 RSUs."}],"balance_after":157570,"source":{"system":"sec-edgar","filing":"0001610717-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000129/form4.xml","form_type":"4"}},{"id":866109,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T02:08:37.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":47600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":47600,"derivative":{"exercise_price":102.02,"expiration_date":"2036-02-28","underlying":"Common Stock","underlying_shares":47600},"source":{"system":"sec-edgar","filing":"0001610717-26-000081","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000081/form4.xml","form_type":"4"}},{"id":866108,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-04T02:08:37.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":21100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 82,326 restricted stock units."}],"balance_after":162153,"source":{"system":"sec-edgar","filing":"0001610717-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000081/form4.xml","form_type":"4"}},{"id":941987,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-09T21:20:44.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":false,"shares":23594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":119906,"derivative":{"exercise_price":29.8,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":23594},"source":{"system":"sec-edgar","filing":"0001610717-26-000013","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000013/form4.xml","form_type":"4"}},{"id":941986,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-09T21:20:44.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":false,"shares":51406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025."}],"balance_after":1094,"derivative":{"exercise_price":42.45,"exercise_date":"2023-08-09","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":51406},"source":{"system":"sec-edgar","filing":"0001610717-26-000013","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000013/form4.xml","form_type":"4"}},{"id":941985,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:20:44.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":102.9,"value":174930.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,226 restricted stock units."}],"balance_after":141053,"source":{"system":"sec-edgar","filing":"0001610717-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000013/form4.xml","form_type":"4"}},{"id":941984,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:20:44.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":20204,"price":101.7928,"value":2056621.7312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $101.07 to $101.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,226 restricted stock units."}],"balance_after":142753,"source":{"system":"sec-edgar","filing":"0001610717-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000013/form4.xml","form_type":"4"}},{"id":941983,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:20:44.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":53096,"price":100.0164,"value":5310470.7744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $100.00 to $100.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,226 restricted stock units."}],"balance_after":162957,"source":{"system":"sec-edgar","filing":"0001610717-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000013/form4.xml","form_type":"4"}},{"id":941982,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:20:44.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":true,"shares":23594,"price":29.8,"value":703101.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,226 restricted stock units."}],"balance_after":216053,"source":{"system":"sec-edgar","filing":"0001610717-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000013/form4.xml","form_type":"4"}},{"id":941981,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:20:44.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":true,"shares":51406,"price":42.45,"value":2182184.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,226 restricted stock units."}],"balance_after":192459,"source":{"system":"sec-edgar","filing":"0001610717-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071726000013/form4.xml","form_type":"4"}},{"id":963036,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-18T21:16:05.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":4847,"price":76.8173,"value":372333.4531,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,226 restricted stock units."}],"balance_after":141053,"source":{"system":"sec-edgar","filing":"0001610717-25-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071725000421/form4.xml","form_type":"4"}},{"id":1036221,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-18T20:36:43.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":4775,"price":45.8249,"value":218813.8975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 70,500 restricted stock units."}],"balance_after":145900,"source":{"system":"sec-edgar","filing":"0001610717-25-000348","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071725000348/form4.xml","form_type":"4"}},{"id":1106116,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-06-18T20:06:54.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":3510,"price":39.83,"value":139803.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $39.6017 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 79,776 RSUs."}],"balance_after":150675,"source":{"system":"sec-edgar","filing":"0001610717-25-000242","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071725000242/form4.xml","form_type":"4"}},{"id":1110370,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T20:05:10.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":50000,"derivative":{"exercise_price":0.503,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-017370","document":"form4-06162025_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925017370/form4-06162025_040607.xml","form_type":"4"}},{"id":1110369,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:05:10.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the earlier of (a) June 12, 2026 or (b) the day prior to the 2026 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,251 shares subject to the Reporting Person's December 15, 2022 RSU grant that will vest in one final  installment on December 15, 2025."}],"balance_after":82650,"source":{"system":"sec-edgar","filing":"0001415889-25-017370","document":"form4-06162025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925017370/form4-06162025_040607.xml","form_type":"4"}},{"id":1196927,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-19T21:41:43.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":3058,"price":39.0403,"value":119385.2374,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 89,050 RSUs."}],"balance_after":153533,"source":{"system":"sec-edgar","filing":"0001610717-25-000078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071725000078/form4.xml","form_type":"4"}},{"id":1227516,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T00:02:03.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":100100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":100100,"derivative":{"exercise_price":40.74,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":100100},"source":{"system":"sec-edgar","filing":"0001610717-25-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071725000053/form4.xml","form_type":"4"}},{"id":1227515,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:02:03.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":28600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 97,476 restricted stock units."}],"balance_after":156591,"source":{"system":"sec-edgar","filing":"0001610717-25-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071725000053/form4.xml","form_type":"4"}},{"id":1326485,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-12-18T21:09:47.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":4329,"price":45.4038,"value":196553.0502,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 68,876 RSUs."}],"balance_after":127991,"source":{"system":"sec-edgar","filing":"0001610717-24-000547","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000547/form4.xml","form_type":"4"}},{"id":1386602,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-15T21:31:22.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":false,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024."}],"balance_after":97382,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0001610717-24-000509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000509/form4.xml","form_type":"4"}},{"id":1386601,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-15T21:31:22.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":false,"shares":44631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024."}],"balance_after":0,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":44631},"source":{"system":"sec-edgar","filing":"0001610717-24-000509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000509/form4.xml","form_type":"4"}},{"id":1386600,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-10-15T21:31:22.000Z","date":"2024-10-11","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":50.3411,"value":2517055.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $50.00 to $50.82, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 77,300 restricted stock units."}],"balance_after":132320,"source":{"system":"sec-edgar","filing":"0001610717-24-000509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000509/form4.xml","form_type":"4"}},{"id":1386599,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-10-15T21:31:22.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":true,"shares":5369,"price":4.09,"value":21959.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 77,300 restricted stock units."}],"balance_after":182320,"source":{"system":"sec-edgar","filing":"0001610717-24-000509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000509/form4.xml","form_type":"4"}},{"id":1386598,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-10-15T21:31:22.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":true,"shares":44631,"price":4.09,"value":182540.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 77,300 restricted stock units."}],"balance_after":176951,"source":{"system":"sec-edgar","filing":"0001610717-24-000509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000509/form4.xml","form_type":"4"}},{"id":1403425,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-09-18T20:17:43.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":4331,"price":44.1853,"value":191366.5343,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 77,300 RSUs."}],"balance_after":132320,"source":{"system":"sec-edgar","filing":"0001610717-24-000487","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000487/form4.xml","form_type":"4"}},{"id":1472996,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-06-20T20:12:17.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":4415,"price":37.387,"value":165063.605,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $37.3868 to $37.3875, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,513 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 85,726 RSUs."}],"balance_after":136651,"source":{"system":"sec-edgar","filing":"0001610717-24-000350","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000350/form4.xml","form_type":"4"}},{"id":1488911,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:24:27.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":50000,"derivative":{"exercise_price":0.5676,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-015755","document":"form4-06062024_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924015755/form4-06062024_080623.xml","form_type":"4"}},{"id":1488910,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:24:27.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the earlier of (a) June 4, 2025 or (b) the day prior to the 2025 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,500 shares subject to the Reporting Person's December 15, 2022 RSU grant that will vest in two equal annual installments of 6,250 shares on each of December 15, 2024 and 2025."}],"balance_after":57650,"source":{"system":"sec-edgar","filing":"0001415889-24-015755","document":"form4-06062024_080623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924015755/form4-06062024_080623.xml","form_type":"4"}},{"id":1565826,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-20T20:44:58.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":2914,"price":31.5832,"value":92033.4448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of RSUs after July 15, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 94,150 RSUs."}],"balance_after":139553,"source":{"system":"sec-edgar","filing":"0001610717-24-000172","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000172/form4.xml","form_type":"4"}},{"id":1578548,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-13T20:32:01.000Z","date":"2024-03-12","kind":"exercise","planned":true,"acquired":false,"shares":7936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."}],"balance_after":44631,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":7936},"source":{"system":"sec-edgar","filing":"0001610717-24-000160","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000160/form4.xml","form_type":"4"}},{"id":1578547,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-13T20:32:01.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":false,"shares":15735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."}],"balance_after":52567,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":15735},"source":{"system":"sec-edgar","filing":"0001610717-24-000160","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000160/form4.xml","form_type":"4"}},{"id":1578546,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-13T20:32:01.000Z","date":"2024-03-12","kind":"sale","planned":true,"acquired":false,"shares":7936,"price":34.0657,"value":270345.3952,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $34.00 to $34.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 100,013 restricted stock units."}],"balance_after":142467,"source":{"system":"sec-edgar","filing":"0001610717-24-000160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000160/form4.xml","form_type":"4"}},{"id":1578545,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-13T20:32:01.000Z","date":"2024-03-12","kind":"exercise","planned":true,"acquired":true,"shares":7936,"price":4.09,"value":32458.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 100,013 restricted stock units."}],"balance_after":150403,"source":{"system":"sec-edgar","filing":"0001610717-24-000160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000160/form4.xml","form_type":"4"}},{"id":1578544,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-13T20:32:01.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":15735,"price":34.0201,"value":535306.2735,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $34.00 to $34.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 100,013 restricted stock units."}],"balance_after":142467,"source":{"system":"sec-edgar","filing":"0001610717-24-000160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000160/form4.xml","form_type":"4"}},{"id":1578543,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-13T20:32:01.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":true,"shares":15735,"price":4.09,"value":64356.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 100,013 restricted stock units."}],"balance_after":158202,"source":{"system":"sec-edgar","filing":"0001610717-24-000160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000160/form4.xml","form_type":"4"}},{"id":1595132,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T21:55:20.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":143500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":143500,"derivative":{"exercise_price":29.8,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":143500},"source":{"system":"sec-edgar","filing":"0001610717-24-000134","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000134/form4.xml","form_type":"4"}},{"id":1595131,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:55:20.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,013 restricted stock units."}],"balance_after":142467,"source":{"system":"sec-edgar","filing":"0001610717-24-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071724000134/form4.xml","form_type":"4"}},{"id":1704640,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-20T00:30:46.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."}],"balance_after":68302,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001610717-23-000407","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000407/form4.xml","form_type":"4"}},{"id":1704639,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:30:46.000Z","date":"2023-12-18","kind":"sale","planned":true,"acquired":false,"shares":2993,"price":25.9018,"value":77524.0874,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of RSUs after July 15, 2023."},{"field":"shares","element":"transactionShares","label":"F5","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades in prices ranging from $25.9016 to $25.9219, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 59,013 restricted stock units (\"RSUs\")."}],"balance_after":101467,"source":{"system":"sec-edgar","filing":"0001610717-23-000407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000407/form4.xml","form_type":"4"}},{"id":1704638,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:30:46.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":26.6366,"value":133183.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $26.04 to $26.93, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 59,013 restricted stock units (\"RSUs\")."}],"balance_after":104460,"source":{"system":"sec-edgar","filing":"0001610717-23-000407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000407/form4.xml","form_type":"4"}},{"id":1704637,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:30:46.000Z","date":"2023-12-15","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":4.09,"value":20450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 59,013 restricted stock units (\"RSUs\")."}],"balance_after":109460,"source":{"system":"sec-edgar","filing":"0001610717-23-000407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000407/form4.xml","form_type":"4"}},{"id":1717695,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-08T21:08:08.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."}],"balance_after":73302,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001610717-23-000393","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000393/form4.xml","form_type":"4"}},{"id":1717694,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-12-08T21:08:08.000Z","date":"2023-12-06","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":25,"value":125000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units."}],"balance_after":104460,"source":{"system":"sec-edgar","filing":"0001610717-23-000393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000393/form4.xml","form_type":"4"}},{"id":1717693,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-12-08T21:08:08.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":4.09,"value":20450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units."}],"balance_after":109460,"source":{"system":"sec-edgar","filing":"0001610717-23-000393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000393/form4.xml","form_type":"4"}},{"id":1755174,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-25T22:20:49.000Z","date":"2023-10-25","kind":"exercise","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5941,"derivative":{"exercise_price":0.54,"exercise_date":"2022-03-01","expiration_date":"2028-02-11","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001610717-23-000315","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000315/form4.xml","form_type":"4"}},{"id":1755173,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-25T22:20:49.000Z","date":"2023-10-25","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":0.54,"value":4050.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 64,875 restricted stock units."}],"balance_after":104460,"source":{"system":"sec-edgar","filing":"0001610717-23-000315","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000315/form4.xml","form_type":"4"}},{"id":1758007,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-18T20:23:44.000Z","date":"2023-10-16","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."}],"balance_after":78302,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001610717-23-000310","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000310/form4.xml","form_type":"4"}},{"id":1758006,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-18T20:23:44.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":400,"price":34.995,"value":13998.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades in prices ranging from $34.76 to $35.18, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units."}],"balance_after":96960,"source":{"system":"sec-edgar","filing":"0001610717-23-000310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000310/form4.xml","form_type":"4"}},{"id":1758005,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-18T20:23:44.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":23200,"price":34.0186,"value":789231.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades in prices ranging from $33.73 to $34.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units."}],"balance_after":97360,"source":{"system":"sec-edgar","filing":"0001610717-23-000310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000310/form4.xml","form_type":"4"}},{"id":1758004,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-18T20:23:44.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":800,"price":33.2288,"value":26583.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $32.72 to $33.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units."}],"balance_after":120560,"source":{"system":"sec-edgar","filing":"0001610717-23-000310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000310/form4.xml","form_type":"4"}},{"id":1758003,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-18T20:23:44.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":500,"price":31.956,"value":15978.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $31.41 to $32.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units."}],"balance_after":121360,"source":{"system":"sec-edgar","filing":"0001610717-23-000310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000310/form4.xml","form_type":"4"}},{"id":1758002,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-18T20:23:44.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":100,"price":30.15,"value":3015.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units."}],"balance_after":121860,"source":{"system":"sec-edgar","filing":"0001610717-23-000310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000310/form4.xml","form_type":"4"}},{"id":1758001,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-18T20:23:44.000Z","date":"2023-10-16","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4.09,"value":102250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units."}],"balance_after":121960,"source":{"system":"sec-edgar","filing":"0001610717-23-000310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000310/form4.xml","form_type":"4"}},{"id":1777178,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-19T20:17:02.000Z","date":"2023-09-15","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."}],"balance_after":103302,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001610717-23-000288","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000288/form4.xml","form_type":"4"}},{"id":1777177,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-09-19T20:17:02.000Z","date":"2023-09-18","kind":"sale","planned":true,"acquired":false,"shares":2514,"price":31.3105,"value":78714.597,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades in prices ranging from $31.1010 to $31.3108, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units (\"RSUs\")."}],"balance_after":96960,"source":{"system":"sec-edgar","filing":"0001610717-23-000288","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000288/form4.xml","form_type":"4"}},{"id":1777176,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-09-19T20:17:02.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":32.0817,"value":160408.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $31.60 to $32.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units (\"RSUs\")."}],"balance_after":99474,"source":{"system":"sec-edgar","filing":"0001610717-23-000288","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000288/form4.xml","form_type":"4"}},{"id":1777175,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-09-19T20:17:02.000Z","date":"2023-09-15","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":4.09,"value":20450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,875 restricted stock units (\"RSUs\")."}],"balance_after":104474,"source":{"system":"sec-edgar","filing":"0001610717-23-000288","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000288/form4.xml","form_type":"4"}},{"id":1790727,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-01T20:16:02.000Z","date":"2023-08-31","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."}],"balance_after":108302,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-23-000252","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000252/form4.xml","form_type":"4"}},{"id":1790726,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-09-01T20:16:02.000Z","date":"2023-08-31","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":34.0458,"value":340458.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $34.00 to $34.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 70,738 restricted stock units."}],"balance_after":99474,"source":{"system":"sec-edgar","filing":"0001610717-23-000252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000252/form4.xml","form_type":"4"}},{"id":1790725,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-09-01T20:16:02.000Z","date":"2023-08-31","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":4.09,"value":40900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 70,738 restricted stock units."}],"balance_after":109474,"source":{"system":"sec-edgar","filing":"0001610717-23-000252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000252/form4.xml","form_type":"4"}},{"id":1803337,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T20:17:13.000Z","date":"2023-08-15","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."}],"balance_after":118302,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001610717-23-000229","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000229/form4.xml","form_type":"4"}},{"id":1803336,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-08-17T20:17:13.000Z","date":"2023-08-15","kind":"sale","planned":true,"acquired":false,"shares":1915,"price":30.7993,"value":58980.6595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $30.69 to $30.91, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 70,738 restricted stock units."}],"balance_after":99474,"source":{"system":"sec-edgar","filing":"0001610717-23-000229","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000229/form4.xml","form_type":"4"}},{"id":1803335,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-08-17T20:17:13.000Z","date":"2023-08-15","kind":"sale","planned":true,"acquired":false,"shares":3085,"price":30.3571,"value":93651.6535,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $29.68 to $30.67, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 70,738 restricted stock units."}],"balance_after":101389,"source":{"system":"sec-edgar","filing":"0001610717-23-000229","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000229/form4.xml","form_type":"4"}},{"id":1803334,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-08-17T20:17:13.000Z","date":"2023-08-15","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":4.09,"value":20450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 70,738 restricted stock units."}],"balance_after":104474,"source":{"system":"sec-edgar","filing":"0001610717-23-000229","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000229/form4.xml","form_type":"4"}},{"id":1846343,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-06-22T20:26:02.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":2102,"price":24.891,"value":52320.882,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,514 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 70,738 RSUs."}],"balance_after":99474,"source":{"system":"sec-edgar","filing":"0001610717-23-000194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000161071723000194/form4.xml","form_type":"4"}},{"id":1868073,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T20:48:46.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":27750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":27750,"derivative":{"exercise_price":1.11,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":27750},"source":{"system":"sec-edgar","filing":"0001209191-23-034392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123034392/doc4.xml","form_type":"4"}},{"id":1868072,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T20:48:46.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":13900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the earlier of (a) June 1, 2024 or (b) the day prior to the 2024 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,750 shares subject to the Reporting Person's December 15, 2022 RSU grant that will vest in three equal annual installments 0f 6,250 shares on each of December 15, 2023, 2024 and 2025."}],"balance_after":32650,"source":{"system":"sec-edgar","filing":"0001209191-23-034392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123034392/doc4.xml","form_type":"4"}},{"id":1942836,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-22T00:33:48.000Z","date":"2023-03-17","kind":"sale","planned":false,"acquired":false,"shares":1230,"price":21.78,"value":26789.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $21.4115 to $21.784581, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 76,600 RSUs."}],"balance_after":100062,"source":{"system":"sec-edgar","filing":"0000899243-23-009377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000089924323009377/doc4.xml","form_type":"4"}},{"id":1972619,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T21:16:21.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2023 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":26.5,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001567619-23-004352","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000156761923004352/doc1.xml","form_type":"4"}},{"id":1972618,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-03T21:16:21.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 79,963 restricted stock units."}],"balance_after":101292,"source":{"system":"sec-edgar","filing":"0001567619-23-004352","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000156761923004352/doc1.xml","form_type":"4"}},{"id":2078593,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-21T21:05:45.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":1220,"price":22.9389,"value":27985.458,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $22.4701 to $22.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 39,963 RSUs."}],"balance_after":61292,"source":{"system":"sec-edgar","filing":"0001567619-22-021926","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000156761922021926/doc1.xml","form_type":"4"}},{"id":2082480,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-19T21:45:01.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 36 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":37500,"derivative":{"exercise_price":3.3,"expiration_date":"2032-12-14","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-22-061951","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122061951/doc4.xml","form_type":"4"}},{"id":2082479,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-19T21:45:01.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit grant that will vest in three equal annual installments measured from the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")), through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":18750,"source":{"system":"sec-edgar","filing":"0001209191-22-061951","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122061951/doc4.xml","form_type":"4"}},{"id":2121020,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":37201,"kind":"person","name":"Horn Margaret A","position":1,"cik":"0001294192","reported_name":"Horn Margaret A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-11-09T21:13:50.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":17767,"price":20.1536,"value":358069.0112,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $20.00 to $20.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by Margaret A. Horn Revocable Living Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-019381","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294192/000156761922019381/doc1.xml","form_type":"4"}}],"next_cursor":"2022-11-09T21:13:50.000000Z,2121020"}